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Abstract 
The advantages and disadvantages of genetic modification of organisms (GMOs) for 
agriculture are reviewed. These relate to the environment, human health, economic 
benefits, population growth, and consequences for developed and developing countries. 
An overall evaluation requires that attention is given to uncertainty, risk perception and 
endogeneity, irreversibility, and the trade-off between costs and benefits. The uncertainty 
surrounding both pros and cons explains the wide range of opinions about the use of 
GMOs in agriculture. Given that modern biotechnology is subject to much R&D and 
genetically modified products are already being sold at a large scale, it seems unrealistic, 
and certainly too late, to strive for a complete ban of GMOs. Instead, an effective public 
strategy should include a number of elements: promote communication among science, 
industry, politicians, voters/consumers, and NGOs; focus legislation on responsibilities of 
private firms; correct prices to reflect environmental and health impacts of GMOs 
(externalities); develop standards for monitoring and testing environmental, ecological 
and health consequences of GMO based products; and guarantee consumer choice 
between products based on and products free of production cycles that involve genetic 
engineering or GMOs. 
 
Keywords: Biotechnology, Cost-benefit analysis, Ecology, Evolution, Genetic 
engineering, Health, Irreversibility, Transgenic plants, Uncertainty.
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1. Introduction 
Modern biotechnology, also known as genetic engineering or modification of organisms, 
has recently enjoyed a great deal of public attention, in the media, on internet, and in the 
political arena. Proponents of rapid implementation of this technology, notably in 
agriculture and medicine, point at its beneficial effects on both quality and quantity of 
food produced by agriculture and food processing industries. Biotechnology is argued to 
lead to more nutritious, durable, tasty and cheaper food. Although the debate concerning 
biotechnology in agriculture is taking place mainly in the western world, the major 
potential winners are suggested to be the developing countries. Opponents of 
biotechnology use terms such as “Frankenstein food” and “genetic manipulation” to point 
at its unnaturalness, and the associated dangers, such as negative impacts on human 
health and the natural environment. So far, these counter arguments have come mainly 
(but not exclusively, see Union of Concerned Scientists) from environmental 
organizations, notably Greenpeace (see Greenpeace online). Their writings, however, are 
dominated by emotional considerations and often lack a firm scientific basis. On the other 
hand, many scientists, both biologists and physicians, are openly in favor of genetic 
engineering and actively promote its use. Interestingly, various academic bioengineers 
working at universities are themselves involved in commercially applying their scientific 
findings, making them perhaps not the most objective judges of any risks involved. In 
this article the various opinions will be substantiated with references to relevant 
publications. 
Without any doubt, like any technology, biotechnology has both positive and 
negative consequences. This article aims to examine and compare the pros and cons of 
biotechnology applied to food production. The main focus of attention here will thus be 
the use of genetically modified organisms (GMOs), in particular transgenic plants, in the 
agricultural sector. The discussion comprises biological, environmental, health and 
economic issues. Particular attention will be devoted to the way uncertainty can be 
addressed in evaluating potential social costs and benefits of biotechnology applications. 
The basic motivation for writing this article is the belief that consumers, 
producers, politicians, and activist groups should be properly informed about the risks 
and benefits of biotechnology in order to be able to make deliberate choices about related 
investment, buying, and voting decisions. Nevertheless, it is not clear whether this is a 
realistic goal, given the rather technical nature of the issues involved. These cover an 
extremely wide range of human knowledge: genetics and biochemistry, evolutionary 
biology, ecology, health sciences, ethics, legislation and liability, patenting, new markets, 
takeovers and mergers, trade and globalization, and even psychology (to analyze 
emotional responses). Unfortunately, ill-informed articles are being published on a daily 
basis in newspapers and popular magazines. As social scientists involved in 
environmental research we also run the risk of making these types of mistakes, 
particularly in the area of natural sciences. Nevertheless, a natural scientist would face 
the same problem with the social aspects. A truly multidisciplinary evaluation is therefore 
required. Consequently, someone seriously interested in forming an opinion about the 
role of biotechnology in our society should be willing to invest considerable time and 
effort in studying relevant natural and social science aspects of the issues involved. This 
article offers a first effort in this direction. 
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The organization is as follows. Section 2 presents a definition and a short history 
of biotechnology, as well as some indicators of its economic significance. Section 3 
offers arguments in favor of using GMOs in agriculture, classified into environmental, 
human-economic, and population-development related benefits. Section 4 lists the 
arguments against it, covering environmental, health, social-economic, and population-
development related costs. Section 5 discusses how the pros and cons of biotechnology 
can be evaluated, paying attention to the analysis of risk and uncertainty, the trading-off 
of benefits and costs, and the comparison of alternative options in agriculture. Section 6 
concludes. 
 
2. Biotechnology 
Definition 
Although they are often used synonymously, there is a strict difference between 
biotechnology and genetic engineering. The definition of biotechnology given in 1992 
during the Convention on Biodiversity states that it includes “any technological 
application that uses biological systems, living organisms or derivatives thereof, to make 
or modify products or processes for specific uses” (Committee on Agriculture, 1999, p.2). 
Biotechnology covers all techniques that involve the isolation, amplification, 
modification, and recombination of DNA. Genetic engineering is only one of these 
techniques, but it is by far the most debated. It can be seen as a particular type of 
biotechnology that involves the modification of DNA and the transfer of gene 
components between species in order to encourage replication of certain specific traits 
(Altieri, 1998). Most of the debate on biotechnology, especially in agriculture, focuses on 
the use of genetic engineering to produce genetically modified organisms or transgenic 
products. These various terms will be used throughout the paper. 
 
History 
Biotechnology has been around for centuries. Products such as yogurt, cheese and beer 
have always been made in a process that is presently best referred to as traditional 
biotechnology (McHugen, 2000). To the same category belongs crossbreeding, which 
aims at combining positive traits of different varieties of the same species in order to 
create organisms with certain attractive properties. Since the process of crossbreeding 
combines whole strings of DNA it is limited to mixing varieties of the same species. A 
particular application of crossbreeding is in animal husbandry, where certain varieties of 
a species have been crossed so as to create a wide range of domesticated animals. 
Nowadays, virtually every type of foodstuff, with the exception of wild game and wild 
fruit, has been modified in some way, so as to make it more attractive or resourceful, or 
its production more efficient. This has been done using either traditional or modern 
biotechnology. 
Modern biotechnology is a relatively young technology. It can be classified into 
the genetic modification of plants, animals or micro organisms that are used either for 
agricultural, medicinal or industrial purposes. Recombinant-DNA techniques, which are 
at its basis, were first applied in the 1970’s. They allowed the cutting and slicing of genes 
of one organism and the insertion of them into another organism, thus changing the 
latter’s production of certain proteins so as to indirectly remove from it undesirable or 
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add to it desirable features.1 The first genetically modified plants were produced in 1983 
and the first modified whole food entered the market in 1994 (McHugen, 2000). The 
fundamental difference between traditional biotechnology and genetic engineering is that 
the latter allows the crossing of species’ boundaries. Genetic engineering even allows the 
transfer of genes from animals to plants and vice versa. 
 
Biotech companies 
Although the modern biotech industry is young, it has experienced a tremendous growth 
over the past three decades. Sales have been estimated to grow 16% over 1999 leading to 
an estimated US$18.6 billion in revenues (Morrison, Giovannetti et al., 1998). The 
growth of sales of transgenic crops has been even more dramatic. In 1995 global sales 
were estimated at US$75 million, while for 1999 estimates range between US$2.1 and 
US$2.3 billion. Furthermore, total sales for the year 2010 are estimated to reach US$25 
billion (James, 1999). 
Research and development (R&D) plays a very important role in the 
biotechnology industry. In 1999, the US biotech industry spent an estimated US$9,9 
billion on R&D (Morrison, Giovannetti et al., 1998). To see the relevance of GMOs for 
production of staples in agriculture, note that in 1999 genetically modified soya in USA 
used on average 50% of total land use by soya. For maize the equivalent figure is 34% 
(James, 1999). 
There are also several public sector organizations involved in the biotechnological 
research and production process. Most public research focuses on seeking benefits 
involving small scale farmers and improving production in tropical and subtropical 
environments (The Third World Academy of Sciences, 2000). However, current funding 
for international agricultural research centers is less than US$350 million while the 
support provided by the US government for agricultural research has dropped by about 
30% in real terms since 1960 (Shah and Strong, 1999). The result is that unlike during the 
green revolution where public organizations played a mayor strategic roles, the main 
players in biotechnology development are private, profit seeking firms. 
Responses by consumers, NGOs and even countries already have had quite a lot 
of influence on the operations and marketing of the private biotech companies. Several 
large food companies have recently changed their strategies based on fear for their 
reputation and market share. This does not mean, however, that the production of 
genetically modified products is decreasing. The main change is that certain products that 
contain artificially modified proteins are not being sold to consumers at this moment. But 
a range of other products like butter, cookies, soups, bread and sauces with ingredients 
from GMOs are still available. Environmental NGOs claim that firms in the foodstuff 
industry pay little attention to the production methods of the ingredients of their products 
(Reijnders, 2000). In this sense biotechnology is no exception; standards for labor, 
environmental and biotechnological characteristics of products and production processes 
have been discussed at an international level for a long time now, notably in a 
GATT/WTO context. It is just a matter of time before such standards will be 
                                                                 
1 The blueprint for each organism is the set of chromosomes or DNA molecules in each of its cells. These 
molecules consist of building blocks called genes. Certain groups of genes provide the code for the 
production of particular proteins. 
 
 5
internationally agreed upon, including those relating to applications of modern 
biotechnology. 
 
3. Arguments in favor of biotechnology  
While the application of modern biotechnology is relatively new, the benefits to farmers, 
consumers and the environment should be viewed in a long term perspective. The 
arguments presented in favor of biotechnology can be divided into three categories, 
namely environmental benefits, human-economic benefits, and benefits associated with 
population growth in developing countries. 
 
Environmental benefits  
Although agriculture offers many opportunities for biotechnological applications, most 
efforts have been focused on using genetic engineering to either develop herbicide 
tolerant crops or pest and disease resistant crops (Altieri, 1998). Herbicide Resistant 
Crops (HRCs) contain a new gene that protects the crop against harmful effects of certain 
weed killers. Farmers can then spray these crops with the relevant herbicides to kill off all 
the weeds while leaving the crops unharmed. The use of these crops could lead to a 
reduction in the use of herbicide due to the following reasons. First, the application rates 
for some of the herbicides used on HRCs are less than the application rates of the 
herbicides being replaced. Second, multiple herbicide treatments on normal crops could 
be replaced by one herbicide treatment on HRCs, reducing the overall quantity of 
herbicide. Lastly, herbicides are often used as pre-emerging options, meaning agricultural 
land is treated for weeds before the weeds emerge as this is easier than if the weeds had 
to be dealt with once the crop is up. As the quantity of weeds is unknown, the farmer is 
unsure about what the damage the weeds will cause. As a form of personal insurance and 
a prevention of loosing a large portion of his crop, the farmer may spray more than 
necessary. In contrast, using HRCs will lead to a greater use of post emergence treatment, 
meaning spraying after the crop is up. The farmer can then weigh the costs of another 
herbicide treatment against the possible damages incurred by the weeds. The resulting 
increase in effectiveness of herbicide spraying due to the use of biotechnology could 
reduce the overall use of herbicides, although certainly not make it superfluous. (Krimsky 
and Wrubel, 1996). 
The validity of these arguments depends on the behavioral responses of farmers. 
It could be expected that because of the increased simplicity and efficiency of the 
herbicide, farmers would use it on more crops over longer periods of the growing season. 
The overall result would be an increase in the total amount of herbicide use. Two factors, 
however, make it less likely that an increase in herbicides will occur. First, herbicides are 
already used intensively. Over 90% of all cotton, corn and soybean acreage in the US is 
treated with herbicides at least once a year (Krimsky and Wrubel, 1996). Second, the first 
experiences with genetically modified cotton show an increase in yield and net  return 
while using a stable quantity of herbicides. At the same time, for soya a small increase in 
yield and a significant reduction in herbicide use were found (Klotz-Ingram et al., 1999).  
Recently, much attention has been given to crops that can produce an insect-
killing toxin called Bt, named after the soil microorganism Bacillus thuringiensis that has 
been used for several decades as an insect repellent. Scientists have been able to isolate 
the genes of the microorganism that produces the toxin and insert these into various types 
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of plants. This allows the resulting genetically modified plants to produce their own 
toxin. Those in favor of this type of biotechnology note that as the crops themselves now 
produce an insect killing toxin, there is no more need to spray so that the expected overall 
effect is a reduction in insecticide use. 
One particular transgenic crop producing Bt, namely modified corn, has given rise 
to much negative public response. Studies have assessed negative effects of genetically 
modified corn pollen on monarch butterfly caterpillars, in particular since it killed 
monarch butterfly larvae (Losey et al., 1999). Opponents mention this as a prime example 
of the ecological risks associated with genetically modified crops. One should be careful, 
however, in drawing quick conclusions, since new research has stated that the overall 
effect in this particular case was not worrisome, and not greater than ex ante expected 
(MacKenzie, 1999). 
In the past five decades, more than a quarter of the world's cropland, pastures and 
woodlands has degraded through misuse or overuse. Additionally, approximately 70% 
(and up to 90% in China and India) of the world’s fresh water supply is being used for 
agricultural purposes, while it is expected that by the year 2025, one quarter of the world 
population will lack an adequate supply of fresh water (Shah and Strong, 1999). A 
potential environmental benefit of transgenic crops is that in the future they may allow 
the use of marginal lands for farming purposes. This requires the creation of crops that 
can grow on salty, dry or acidic soils. As an indirect effect deforestation for creating 
cropland could be reduced. Nevertheless, progress in developing such improved crops is 
rather slow, due to the fact that many more genes are involved, making the engineering 
task much more complicated than in the case of, for example, the creation of herbicide 
tolerant or pest resistant crops. 
 
Human and economic benefits 
The main human and economic benefits of agricultural biotechnology are an increase in 
food quantity and quality, reduced costs of production, and ultimately lower prices of 
agricultural products. 
Improving food quality involves features like an improvement of texture, taste, 
appearance, and nutritional value. In addition, the ripening of fruits and vegetables can be 
delayed. Examples of this are increasing the dry matter content of a tomato (Le Buanec, 
1999; McHugen, 2000), increasing the concentration of unsaturated fatty acids in soya 
beans, and altering seed storage proteins (Mazur et al.,1999; McHugen, 2000). Specific 
improvements for producers are an increased flexibility during production, harvesting, 
storage, distribution, and transport stages, leading to a reduction of overall production 
costs. The main changes for consumers are enhanced durability, higher quality, and lower 
prices of products. 
An important feature of agricultural biotechnology is its potential to increase the 
nutritional value of food. Approximately 125 million children have a diet that lacks a 
sufficient quantity of vitamin A, leaving some 14 million children with irreparable eye 
damage (Shah and Strong, 1999). Furthermore, is estimated that 30% of the world 
population suffers from a lack of iron in their diet, leading to learning disabilities, an 
increase of infections, and a reduction in the capacity to deliver work. Biotechnology 
scientists have now created a rice variety that produces significant amounts of vitamin A. 
 7
Other varieties are developed that will contain about twice the amount of iron in the 
current rice (McGloughlin, 1999). 
In addition, biotechnology can increase crop yields, which is particularly useful 
for important staple food such as potatoes, rice, maize, wheat, cassava, and beans 
(McHugen, 2000). This can be done in various ways. In the first place, the transgenic 
characteristics discussed above indirectly contribute to a higher productivity of 
agriculture. In addition, specific techniques are available for increasing yield of single 
plants. An example is the so-called dwarfing technique, which focuses production of 
plants in the reproductive parts (Peng et al., 1999). This is useful when these are the 
source of food products, which is the case for a large number of fruits. 
Another future innovation expected from biotechnology is edible vaccines. These 
could have a much greater impact at a fraction of the cost than the current actions by 
international institutions like the World Health Organization (McGloughlin, 1999; 
McHugen, 2000). 
 
Benefits related to population growth and developing countries 
An important argument in favor of biotechnology is the idea that it is essential for 
guaranteeing sufficient food to feed future world populations. It is estimated that 
currently approximately 840 million people suffer from hunger every day. Furthermore, 
while the world population is expected to increase by more than 2 billion until 2020, 
productivity gains in agriculture have dropped to about 1.3% per year, half of what they 
were 30 years ago (Shah and Strong, 1999). In the absence of productivity gains or a 
world wide expansion of cropland, a global shortage of food at some future date is 
conceivable. 
Over 80% of the population will be living in developing countries. It is likely that 
by the year 2020, developing countries will have turned from being net exporters of 
agricultural products to net importers. Unsustainable agriculture is a significant problem 
for many of these developing countries, and biotechnology could play an important role 
in alleviating it (Committee on Agriculture, 1999; Conway, 2000). Low cost, high 
resistance, and high yielding crops are possible solutions that may prove to be valuable in 
preventing future famines. Biotechnology can contribute to a production of larger 
quantities of food and an increase of the nutritional value of different types of food. Some 
think that biotechnology will perhaps not relieve all poverty or social imbalances in 
developing countries, but it does have the potential to improve the position of many 
chronically underfed people, i.e. the extremely poor in this world. Nevertheless, it should 
be noted that the majority of the research on transgenetic plants is of private origin and 
focuses on the production of crops grown in developed countries. Therefore, unless 
government spending increases or private investment is stimulated in another direction, 
the benefits for developing countries and their populations will remain rather small. 
 
4. Arguments against the use of biotechnology 
The arguments against modern biotechnology in agriculture can be divided into four 
categories: ecological and environmental impacts, human health impacts, population 
growth, and general social-economic consequences. 
In addition, there are ethical and religious arguments against the use of biotechnology. 
These are beyond the scope of this article (see, e.g., Nuffield council on Bioethics, 1999). 
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Ecological and environmental issues 
There are at least four main environmental and ecological aspects that should be 
mentioned. First, crops may transfer genes to wild varieties. Second, genes may be 
transferred into the soil. Third, insects can become resistant to the pesticides produced. 
Finally, non-target species in a wider ecosystem context may be affected in some way. 
Each crop is member of a plant family to which many different varieties of the 
same species belong. By introducing new genes into an existing crop, scientists are 
creating a new variety of the plant, which in turn may effect the surrounding 
environment, including other varieties of the same species. The danger is that genes of 
the genetically modified crop transfer to other wild or domesticated varieties of the same 
crop. 
One of the most important risks of using genetically modified crops is that they 
may influence the original natural or wild species that is the source of the domesticated, 
agricultural crop. For instance, if genes, such as herbicide tolerant genes, are inserted into 
a crop with the purpose of fortifying it, then a flow of these genes to the wild variety can 
improve the fitness of the latter. It may become resistant to herbicides and thus dominate 
under natural conditions, possibly reducing the genetic variety of the original wild 
species (Altieri, 1998). This problem is similar to that of newly introduced exotic species. 
These often meet little control from natural enemies or competitors in ecosystems where 
they enter, so that they can grow quickly in population size and damage the original 
species as well as the ecosystem. In a similar way a gene flow from transgenic species to 
wild relatives creates a risk to local and ultimately global biodiversity. 
Another serious problem is related to the fact that wild relatives of crop plants  
provide a source of genetic diversity that is essential for maintaining the quality and 
desirable characteristics of the domesticated species. Therefore, to preserve agriculturally 
relevant biodiversity wild relatives of crop species need to be protected from direct 
influences, in particular genetically modified relatives. These should be kept as much as 
possible spatially separated. Nevertheless, in 1996 the EU allowed a GMO, namely a type 
of coleseed to be grown in Europe, which is its area of origin. This implies a direct risk 
for the wild relative and thus for the biodiversity that is of value to future agriculture. 
Research that has tried to assess the probability of gene transfers from genetically 
modified crops to other varieties tempers the above concerns somewhat. The results show 
that the probability of gene transfers from crops created through genetic modification is 
small, and in fact similar to that for crops created through the use of crossbreeding. An 
explanation for this is that wild species have been adapting to their surroundings for a 
very long time, being subject to continuous selection pressure. Newly created, genetically 
modified varieties that have not passed such a selection and adaptation process are 
expected to perform less well under natural conditions (The Royal Society, 1998). On the 
other hand, these considerations do not provide any safeguard. Moreover, it should be 
noted that as genetically modified crops have been grown on a large scale for only a short 
period of time, more research is needed to provide for more robust empirical results. 
Next, GMOs may affect species that are genetically unrelated but ecologically 
related, such as their predators, preys, and competitors. Several types of influences can be 
identified. To begin with, the effect that the newly inserted genes may have on (soil) 
bacteria is thus far unknown. Even though it is thought to be highly unlikely that the 
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effect will be great, it is known that bacteria can absorb DNA from the environment. The 
consequences of this remain to be seen. 
Furthermore, biotechnology can speed up the creation of resistance in weeds and 
insects against herbicides and insect killers that are being used. As large quantities of 
genetically modified corn, cotton, soya and rice is produced which generate Bt, or which 
are resistant to certain herbicides, the chance of adaptation by weeds and insects to the 
combination of GMOs and use of herbicides and insecticides is high (Stix, 1998). 
External use of Bt has been common practice since the 1940’s. It is considered the most 
effective microbial insecticide. Nevertheless, its sales represent little over 1% of total 
insecticide sales, as treatment of crops is mainly based on synthetic insecticides (Krimsky 
and Wrubel, 1996). So far it has turned out to be an effective insect control for home 
gardening purposes, but the possibility of a reduction in its effectiveness due to GMOs 
producing Bt is very real. 
Finally, the effect of transgenic crops on the wider ecosystem can occur, among 
others, via negative or positive impacts on non target species, usually insects, or via 
changes in farm management that influence local biodiversity (Hails, 2000). An example 
of a positive impact on a species is an ecological advantage due to genes contributing to 
pest resistance. This can in turn have a disturbing impact on the foodweb in the 
ecosystem. Such effects are not unlikely since farmland is usually close to natural areas 
providing a habitat for wild species. 
Another relevant issue here is that perfection of crops through genetic 
modification promotes monocultures. Different varieties of the same crop are becoming 
increasingly similar in genetic composition. Once genetic differences are lost resistance 
against insects is less. Therefore, an insect plague or disease can successfully attack the 
respective crop and do damage to all varieties. The creation of a monocultures magnifies 
the effect of such an attack (Altieri, 1998). It should be noted here that crop production 
with monocultures, particularly in developing countries, runs the risk of being more 
susceptible to erosion as well as to price fluctuations due to economic business cycles. 
Moreover, some authors have claimed that malnutrition can be directly attributed to 
technology, as this has reduced the diversity of many diets and made people dependent 
on a small group of products (Grain, 2000). Modern biotechnology may contribute to an 
increase in the likelihood or magnitude of such effects of monocultures. 
 
Health issues 
One of the problems concerning genetic modification is that the inserted genes may cause 
allergic reactions in certain people. For example, the introduction of a gene of a Brazilian 
nut in soya beans caused allergic reactions from people allergic to the nut (McHugen, 
2000). Scientists have countered this argument by mentioning that there has been only 
one known case in which it was a problem, and that in the future it will be possible to 
extract the gene causing the allergy (Royal Society, 1998). This, however, does not solve 
the current problem that genetic modification could cause future allergies. Without proper 
labeling this problem will remain and consumers could have an allergic reaction without 
being able to locate the possible source of the reaction. 
One of the fears of new transgenic crops is that the insertion of a new gene may 
lead to an unexpected reaction and the production of toxins. The advantage of a GMO, 
however, is that the knowledge which genes have been inserted makes toxicological 
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testing easier than in the case of an organism obtained through traditional crossbreeding 
(The Third World Academy of Sciences, 2000). 
Another problem that has been pointed out is the insertion of antibiotics in crops. 
The antibiotics do not serve a purpose in the final product but have been inserted only to 
facilitate growth of the crop. When the final product is eaten, the antibiotic genes may 
come into contact with bacteria in the digestive system of people and animals, thus 
creating resistance against the respective antibiotics in these bacteria. This in turn could 
weaken future use of the respective antibiotic as a medicine. To counter this argument, 
researchers claim they have been successful in extracting antibiotics in certain cases 
before the respective food was developed for consumption (The Third World Academy of 
Sciences, 2000). Additionally, the risk and effects of the insertion of antibiotics is seen as 
relatively small compared with the current (ab)use of antibiotics as a prescription 
medicine for various diseases (The Royal Society, 1998). 
 
Population growth  
Do GMOs contribute to a stable food provision at a global scale, particularly in 
developing countries? It is often argued that the main problem is not so much the total 
supply of food, but its accessibility, distribution and sustainable production. In addition, 
socio-economic factors such as poverty play a role. Currently the food supply is sufficient 
for the entire world population, and hunger problems exist mainly due to a lack of 
income. Nevertheless, whether this is also the case in two or three decades remains to be 
seen. Scientists do not agree on how many people the Earth can feed on a sustainable 
basis. Wide variances in estimates (in the range of at least 1 to 50 billion people) are due 
to differences between studies in terms of assumptions regarding land use, daily required 
intake of energy, and type of diet (see the survey by Cohen, 1995). Many regard it as 
impossible to calculate the number of people that the earth can support, because it 
depends on so many complex interactions between natural, economic, technological and 
demographic factors. It certainly is not a matter of simple extrapolation. 
One can therefore argue that population growth might be stimulated by increasing 
the capacity for food production through the application of modern agricultural 
biotechnology. There is some support for the view that the world is already 
overpopulated, notably because human pressure on ecosystems is beyond natural carrying 
capacities (Vitousek et al., 1986). Taking away barriers to further growth, such as limits 
to food production, risks further overshooting with ultimately ecological collapse in 
hindsight. Of course, in view of the above-presented estimation of world population 
figures this can be debated. 
Although the food problem is often used to motivate further research on and 
application of agricultural biotechnology, most of the research up till now has gone into 
the development of commercial crops that benefit “western” producers (Altieri and 
Rosset, 1999).  
 
Social-economic issues 
Various environmental organizations have stated that the benefits of biotechnology are 
mainly economic ones, notably profits of large multinational companies. Is this statement 
supported by the facts? Genetic codes and biotechnological procedures are subject to 
patenting, which, in combination with product prices that insufficiently reflect 
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environmental damages (“externalities” in economics’ jargon), suggests that 
biotechnology applications are largely influenced by commercial interests (profit 
motives) rather than by balanced social evaluations. 
Moreover, it is expected that a small number of very large firms will soon control 
the biotechnology market. Traditional seed companies have been and will continue to be 
bought by larger chemical and biotechnology (“life science”) multinationals. These 
companies control a strategic package of products such as insecticides and herbicide 
resistant plants that allow for market and price control and cause barriers to entry for new 
firms. Farmers therefore become increasingly dependent on a very small number of firms 
supplying the needed seeds, fertilizers, herbicides, etc. (Krimsky and Wrubel, 1996). Due 
to the patent legislation they have to pay repeatedly (yearly) for seeds. In other words, 
they are legally not allowed to select seeds themselves, although this would give rise to a 
better adaptation of crops to local climate and soil conditions. As a consequence, farmers 
in developing countries will become more dependent on imported seeds, since most 
biotechnological companies are mainly based in the USA and Europe. 
 
5. Uncertainty, irreversibility, tradeoffs, and alternative options  
Risk perception 
Most of the issues raised by the pressure groups concerning health and environmental 
issues involve trying to influence the public safety feeling, in other words, influencing the 
level of a publicly acceptable risk. As Miller (1998) describes, in the public’s perception 
unfamiliar risks tends to be overestimated. People generally have very little knowledge 
and understanding of the history of traditional biotechnology and the achievements of its 
application, let alone the application of modern biotechnology and genetic engineering. 
In this case little information at the right time can shift the balance of opinions. This is 
undesirable, since often the information is partial or simply incorrect. An example of the 
difference in perception of risk between the public and the scientific community is the 
issue of health concerns. While the public sentiment against genetically modified crops 
remains negative mainly due to worries about health problems, a recent press statement 
by the National Research Council sums up the scientific risk: “… the committee is not 
aware of any evidence suggesting that foods on the market today are unsafe to eat as a 
result of genetic modification. Furthermore, we found no strict distinction between the 
health and environment risk posed by plants modified through modern genetic 
engineering techniques and those modified by conventional breeding practices.” 
(Adkinson, News Conference 2000, paragraph 11,12). Nuffield Council on Bioethics 
(1999) makes similar statements. 
 
Endogenous risk 
One cannot assume that risks relating to GMO's are absolute or exogenous (Crocker and 
Shogren, 1999). For instance, in the present context a risk affecting strategy is to limit 
hybridization (Hails, 2000). This can be done, among others, with terminator technology, 
which allows the genetic control of sterility by preventing pollen development or seed 
germination. Such strategies may impact both the likelihood that something will happen 
and the impact of the outcome. Notably the health related effects, and their probabilities, 
of biotechnology can be adapted by ex ante and ex post actions. Ex ante, human 
responses to new products can be tested. Ex post, consumers can decide not to buy 
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certain products, farmers to move away from certain areas, etc. Protection can also result 
from public intervention. All in all, this means that risks of using biotechnology should 
not be considered as objective and exogenous. Risk can be changed by management and 
endogenous responses to perceived or real risks. Moreover, some types of risks are 
insurable. Consequently, risk management in this area should take both natural and 
social-economic aspects into account, in order not to be (at best) inaccurate or (at worst) 
ineffective. 
 The most serious risks, however, relate to ecological damages. Insurance against 
these is often impossible. The impact, such as evolutionary change or loss of ecosystem 
functions, is irreversible and cannot be compensated in financial terms. This brings us to 
the next consideration. 
 
Irreversibility of lost opportunities 
The problem of choosing for or against genetic modification of agricultural crops can be 
cast in a framework of opportunities and irreversible or even path-dependent 
development. These are themes that have been studied in evolutionary economics and 
economics of technology (Arthur, 1989) and economics of nature conservation (Fisher 
and Krutilla, 1985; Porter, 1982). The results of these studies indicate that the historical 
development of technology may be far from economically or socially optimal, since 
technologies get locked in due to increasing returns and network externalities. This has 
relevance for a number of problems studied nowadays, including climate change 
(Kolstadt, 1994) and biotechnology. Different biotechnology scenarios are associated 
with lost opportunities due to certain irreversible processes. Two extreme case scenarios 
are particularly relevant in this context. 
 In a first scenario with large investments made in biotechnology, the 
irreversibility of the resulting quick progress in biotechnology applications has both 
economic and ecological-evolutionary elements. Economic irreversibility is due to an 
increased dependence of agriculture on GMOs. Ecological-evolutionary irreversibility 
involves changes in the genetic composition of species, both crops, wild relatives and 
ecologically related species. 
Another scenario is the rejection of genetically modified products by western 
consumers, which to some extent, is currently happening in most countries in Europe. 
This can eventually have a large negative impact on the biotech industry. This would 
result in potentially foregone future benefits for people now and in the future. Presently, 
the conditions set by donors of development aid and by financial institutions on the use of 
biotechnology already force many developing countries to restrain the import of both 
genetically modified crops and its technology (Paarlberg, 2000). The result is that while 
the discussion of genetically modified crops goes on in the west, the developing nations 
are unable to make their own choices. 
 
Benefit-cost tradeoffs and comparison with alternatives 
Is it reasonable to compare benefits and costs, possibly with correcting for risk-factors? 
Can this serve as a tool for evaluating biotechnology scenarios? In other words, are the 
uncertain benefits worth the uncertain costs? The analysis is complicated, partly since the 
uncertainty is magnified by endogenous ex ante and ex post modification of risks for both 
ecosystems and human health. For instance, some people clearly put a much larger 
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weight on the potential benefits of biotechnology for developing countries, notably 
supporting a food supply for a growing world population, than on the various costs 
associated with biotechnology. 
 Various authors state that a fair comparison of biotechnology scenarios with 
alternative options should not come down to a comparison between GMO based products 
and a lack of these, but between GMO based products and conventional agricultural 
technology (Hails, 2000; The Third World Academy of Sciences, 2000; Tramper, 2000). 
The latter is characterized by intensive production, irrigation, and notably use of 
pesticides, herbicides and fungicides. It is evident that a shift to biotechnology is an 
improvement in many respects, and will not perform structurally worse in others. For 
example, external use of insecticides will have a similar – in magnitude that is – 
evolutionary (or selection) effect as plants with genes producing the same insecticide 
(Krimsky and Wrubel, 1996). Another example is that traditional agriculture also has 
caused gene flows from crops to wild varieties. Hails (2000) gives the example of weed 
beet being a hybrid between sugar beet and wild beet. 
Should traditional agriculture, with all its disadvantages for health and 
environment, act as a benchmark when judging modern biotechnology? This depends on 
the availability of a third alternative, which might be organic farming. The question is 
whether the latter is capable of providing sufficient food to support the world population, 
and how quickly it can be developed compared with alternative scenarios based on 
GMOs. Only if organic farming is a real alternative can it serve as the benchmark. 
 
6. Evaluation and recommendations 
The currently available genetic technology in agriculture mainly focuses on two 
applications, namely herbicide tolerant and insecticide producing crops. This has in some 
cases improved the conditions for western farmers while the only effect it has had on 
consumers is to raise doubts about its safety. The information on both the positive and 
negative effects of genetically modified crops on human health and the environment 
indicates that the effects up till now are minimal. Most scientists involved in the use and 
application of biotechnology perceive long-term benefits and are largely in favor of its 
use. They view the environmental and especially health risks involved as minimal and 
acceptable and regard the potential benefits to outweigh the potential risk. However, low 
risk does not mean no risk, and if the negative effects are larger than expected the 
potential damage could be great and irreversible. What are the considerations that need to 
be taken into account to arrive at a balanced judgement of the use of GMOs in 
agricultural crops? 
The most fundamental characteristics of modern biotechnology from a natural 
science perspective is that changes due to genetic engineering are no longer subject to 
natural selection, and that species boundaries are no longer absolute. With regard to the 
latter, the most extreme example is the mixing of animal and plant genes in single 
chromosomes. The first feature, not being subject to natural selection, applies also to 
classical crossbreeding, but the second one is entirely new. Traditional crossbreeding 
usually implies a trade-off or compromise between one characteristic (e.g., productivity 
or color) and another characteristics, resulting in organisms that are usually very sensitive 
outside a controlled domesticated context, making their spread in nature unlikely. Genetic 
 14 
engineering, however, can circumvent compromises, leading to a relatively high risk of 
spreading the resulting organisms in natural environments. 
The gene flow is not the only possible environmental impact. Biodiversity loss is 
a general category of impacts, which covers damages to crops, wild relatives, pesticides, 
and the wider ecosystem. For instance, herbicide resistant organisms stimulate the use of 
herbicides, antibiotic resistant species create health risks, and genetic engineering in 
general stimulates monocultures that in turn promote erosion and quickly spreading 
diseases. Unfortunately, field experiments with genetically modified crops in isolated 
areas do not provide sufficient information about ultimate ecosystem impacts of using 
such crops in normal agricultural circumstances. This suggests that applications of GMOs 
are always experiments and need to be monitored closely. 
Next, health effects of biotechnology are often exaggerated. Allergies due to 
GMOs can be foreseen or tested and only a few problems have appeared so far. 
Nevertheless, research on environmental and health effects is relatively small compared 
with research on commercial application of genetically modified crops. One should strive 
for more balance in this respect. 
The advantages of genetically modified organisms are overstated. Creating 
features like resistance against desiccation and viruses are much more difficult to arrange 
because they are the result of interplay of many particular genes. Moreover, the main 
reason for the marketing of the current GMOs is not solving the world’s food problem, if 
there is such a problem, but straightforward commercial, profit oriented interests. Finally, 
proponents of genetically modified organisms exaggerate the precision, focus and 
capabilities of the technique. So, although the development of GMOs is relatively new 
and the technology is starting to develop, these considerations suggest that optimism 
about the beneficial effects of GMOs needs to be tempered. 
The public, which has not yet reaped any direct benefits from genetically 
modified crops, continues to have a blurred vision of what the involved potential benefits 
and risk are. The effect of this is felt not only in western countries where acceptance of 
genetically modified crops is minimal, especially in Europe, but also in developing 
countries where the adoption of biotechnology has been insignificant. Since the potential 
value of biotechnology is perhaps greatest in developing countries, it seems obvious that 
they increase their influence on debates and policies relating to biotechnology. Though 
biotechnology is neither the only answer nor a complete answer to the world’s food 
problems, it could play a significant role in improving both the quantity and quality of 
food that is produced worldwide. But if biotechnology is to serve this role for humanity 
then its R&D and application need to be better monitored and steered by social 
evaluations and better informed politicians and voters, rather than only by interests of 
profit seeking multinationals and their shareholders. 
 In view of the many uncertainties and different perceptions of these, as well as the 
problem of trading-off advantages or benefits against disadvantages or costs, a simple 
evaluation of different biotechnology scenarios is very difficult. This partly explains the 
wide range of opinions among organizations and experts. Nevertheless, a careful 
judgement is that the long-term benefits related to production, health and environment are 
clearer and more certain than the disadvantages in terms of health and ecological effects. 
Moreover, when comparing agricultural biotechnology with traditional agricultural 
practices based on pesticide use, which brings along many environmental and health 
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related risks, it is evident that a shift to biotechnology is an improvement in many 
respects. The question, however, is whether traditional agriculture should be the 
benchmark in evaluations of modern biotechnology. Many writers on biotechnology 
assume or explicitly state so. At first sight, the long term impact of modern biotechnology 
may seem much more severe than that of traditional agriculture. But the evolutionary 
consequences of modern biotechnology are not new compared with traditional 
agriculture, so that it is debatable whether they create an extra dimension to the 
uncertainty about (very) long run impacts. A more systematic comparison, including also 
organic agriculture, could support a better judgement of agricultural biotechnology. This 
requires, however, that organic farming is described as a real alternative with the full 
significance of all derived implications. 
Modern biotechnology is subject to much R&D. Many genetically modified 
products are already sold on the market. Agricultural biotechnology is especially rapidly 
diffusing in countries like Argentina, China and the USA. This suggests that the most 
realistic public strategy would be to quickly develop national and international legislation 
that focuses on responsibilities, norms and methods for ex ante testing and ex post 
monitoring of environmental, ecological and health-safety aspects of such products. At 
the same time, democratic decisions need continuous support from scientists that explain 
in clear ways the pros and cons of biotechnology in understandable and non-emotional 
terms. 
Different views exist with regard to the design of public policies aimed at 
influencing R&D and investments in biotechnology. From an uncertainty perspective a 
comparison with nuclear energy seems relevant, which would suggest a policy based on 
the precautionary principle, i.e. producers of GMOs need to prove that negative effects 
are insignificant. Another view is that it is impossible to avoid all risks, which is neither 
chosen as a constraint in other areas of public policy – think of accidents in transport. A 
third view is that people have influenced nature significantly since the beginning of 
agriculture, i.e. the early domestication of animals and plant species. This has led to the 
development of culture and trade, and has stimulated population growth (see Diamond 
1997). From this perspective the emotional argument “GMO food is unnatural” is 
irrelevant; humans inevitably influence and control nature, and are completely dependent 
on non-natural food, be it produced with or without genetic engineering technology. 
Finally, it has been argued that consumers need to decide themselves, implying that 
choice freedom is essential, especially since a discussion based on purely scientific pros 
and cons will never lead to a simple conclusion. It is difficult to guarantee food choice 
freedom, notably the choice of GMO-free products, when GMOs are used at a large 
scale. Ecolabelling, more control and reporting, and separation of product flows are some 
of the actions needed preserve this freedom. Nevertheless, the latter assumes that it is 
possible to completely separate material-product cycles without GMOs from those with 
GMOs. Even if this were possible it would be very costly; so-called “Identity 
Preservation Systems” are needed. Moreover, such a “free choice approach” denies the 
public goods (bads) character of impacts of GMOs on health and ecosystems 
(biodiversity). For this implies that people cannot protect themselves against all 
undesirable effects, notably ecological changes. In other words, completely free choice is 
impossible. Moreover, international relations and trade threaten the freedom of choice. 
The USA, for instance, has argued that other partners, notably the EU, are creating trade 
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barriers by not allowing products based on GMOs. All in all, policy design aimed at free 
choice by consumers is not a simple matter.2 
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